Developer docs
API playgroundTry for free, no card

Search company profiles

Phoenix Group

Full company profile

uuid000gp28

Namestring
Phoenix Group
Legal namestring
PHOENIX Pharma SE
Websiteurl
phoenixgroup.eu
Company typeenum
Private
Founded yearint
1994
Descriptiontext

PHOENIX Group (legal entity PHOENIX Pharma SE) is a privately held, family-owned pharmaceutical wholesale and pharmacy retail group headquartered in Mannheim, Germany. Founded in 1994, the company operates across 29 European countries with approximately 49,000 employees, 224 distribution sites, and over 3,300 owned pharmacies in 17 countries serving roughly 189 million people annually. It runs three integrated business lines: pharmaceutical wholesale to pharmacies and medical facilities, direct pharmacy retail under multi-country brands (BENU across 13 countries, Apotek 1 in Norway, Help Net in Romania, Rowlands Pharmacy in the UK, McCabes in Ireland, plus many regional labels), and pharmacy cooperation programmes that support independent pharmacies through networks such as PHOENIX Pharmacy Partnership, NUMARK, Pharma Point, pharmavie, ADIVA, SZIMPATIKA, VALORE SALUTE, and Pharmactiv. A fourth stream provides logistics, marketing, and distribution services to pharmaceutical manufacturers, leveraging subsidiaries such as transmed, Health Logistics, ADG, and Specific Pharma.

The group's operating technology stack centers on pharmaceutical distribution logistics: temperature-controlled cold-chain handling, automated picking and sorting in distribution centers, patient-individual blister packaging, and the PHOENIX Apothekenportal (a digital pharmacy portal with DATEV accounting integration). PHOENIX has been a participant in the European Medicines Verification System since February 2019 under the EU Falsified Medicines Directive, scanning every prescription pack for authenticity. The company is currently rolling out a lean management program (introduced two years prior and recognized via the LEAN Award 2025), and has set a target of CO2 neutrality in its own operations by 2030 while preparing for the EU Corporate Sustainability Reporting Directive (CSRD).

PHOENIX generates revenue through transaction-based wholesale distribution, pharmacy retail sales, recurring subscription-like fees from pharmacy cooperation programmes, and professional services to pharmaceutical manufacturers. Pricing is negotiated on a contract basis with no public rate cards. The group is led by CEO Sven Seidel and CFO Dr. Carsten Sauerland, with a planned Executive Board transition effective 1 February 2026 in which Joachim Sowada and Wolfgang Wallisch will replace outgoing members Steve Anderson and Stefan Herfeld. No public revenue figures are disclosed.

Short descriptiontext

Phoenix Group is a family-owned European pharmaceutical wholesaler and pharmacy retailer operating 224 distribution sites and over 3,300 owned pharmacies across 29 countries, serving 189 million people annually through integrated wholesale, retail, and pharmacy cooperation programmes.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersMannheim, Germany
HQ citystring
Mannheim
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical wholesale, pharmacy retail, pharmaceutical distribution, pharmacy cooperation, cold chain logistics
Industry2 codes
1Retail & Community Pharmacies (Chain/Independent)
CodeHLAFALAAPrimaryYes
2Specialty Pharmacy & Complex Therapy Management Platforms
CodeHLACAKAGPrimaryNo
NAICS code2 codes
  • Pharmacies and Drug Retailers456110
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Retail-Drug Stores And Proprietary Stores5912
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Wholesale and Retail
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Pharmaceutical Wholesale
TypeTransaction Fee
Description

Distribution of pharmaceutical products from manufacturers to pharmacies and medical facilities across 29 European countries

phoenixgroup.eu
2Pharmacy Retail
TypeTransaction Fee
Description

Operation of over 3,200 owned pharmacies in 17 European countries serving end consumers directly

phoenixgroup.eu
3Pharmacy Cooperation Programmes
TypeSubscription Recurring
Description

Services and support to independent pharmacies through franchise and partnership models across Europe

phoenixgroup.eu
4Services for Pharmaceutical Industry
TypeProfessional Services
Description

Logistics, marketing, and distribution services for pharmaceutical manufacturers

phoenixgroup.eu
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1PHOENIX Pharmazie Wissenschaftspreis
Description

Annual pharmaceutical science award recognizing outstanding research in Germany, Austria, and Switzerland, with prize money of 40,000 euros distributed across four categories.

phoenixgroup.eu
Core offering1 text field

Phoenix Group is a pan-European integrated pharmaceutical healthcare provider that distributes medicines and healthcare products to pharmacies and medical facilities through 224 distribution sites across 29 countries, and operates over 3,200 own pharmacies in 17 countries. The company also runs pharmacy cooperation programmes that supply independent pharmacies with purchasing, marketing, and digital services across Europe.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 189 million people supplied with medicines and healthcare products annually
+2 more records
Product overview1 text field

PHOENIX Group is a pan-European integrated healthcare provider operating three core business segments: pharmaceutical wholesale (224 distribution centers across 29 countries), pharmacy retail (over 3,300 owned pharmacies in 17 countries), and pharmacy cooperation programmes supporting independent pharmacies. The company offers an extensive portfolio of regional sub-brands including BENU (13 countries), Apotek 1 (Norway), Help Net (Romania), Rowlands Pharmacy (UK), McCabes (Ireland), BROCACEF (Netherlands), FARMEXIM (Romania), Nomeco (Denmark), Tamro (5 countries), and numerous other regional pharmacy and wholesale brands. Supporting services include health logistics (Health Logistics, transmed), pharmacy portal technology (PHOENIX Apothekenportal with DATEV integration), patient services (individual blistering, nurse care programmes), and pharmacy cooperation networks (NUMARK, Pharma Point, VALORE SALUTE, Pharmactiv, and others) spanning over 29 countries. The company employs approximately 49,000 colleagues serving 189 million people annually across Europe.

Product and service8 records
1Pharmaceutical Wholesale
2Pharmacy Retail
CategoryPharmacy Retail
3Pharmacy Cooperation Programmes
CategoryPharmacy Services
4Healthcare Logistics Services
CategoryHealthcare Logistics
5PHOENIX Apothekenportal (Pharmacy Portal)
CategoryDigital Platform
6Patient Individual Blistering
CategoryPatient Services
7Nurse Care Programme
CategoryPatient Services
8Services for Pharmaceutical Industry
CategoryPharmaceutical Services
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Expanded strategic partnership announced at LINDA Delegiertenkongress 2022, providing enhanced cooperation between PHOENIX Pharmahandel and LINDA independent pharmacy network in German-speaking markets.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2019-01-01
Description

PHOENIX Group participates in the EU Falsified Medicines Directive (FMD) verification system, scanning every prescription medicine package for authenticity since February 2019.

Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2005-01-01
Description

Long-standing partnership since 2005 for loyalty programme integration, recently expanded with long-term extension. Provides consumer loyalty services through pharmacy networks.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

DocMorris is a pan-European online pharmacy and healthcare platform headquartered in the Netherlands, competing directly with PHOENIX's retail pharmacy brands (Brocacef, Apotek 1, Help Net) on cross-border mail-order prescription and OTC business.

TypeBroad incumbent
Description

Walgreens Boots Alliance is a global pharmacy-led health and wellbeing enterprise whose Alliance Healthcare wholesale arm and Boots retail pharmacy network compete with PHOENIX's wholesale and retail pharmacy segments across Europe.

TypeBroad incumbent
Description

McKesson is a global pharmaceutical distributor and healthcare services company that previously owned Celesio/Lloyds Pharmacy, directly overlapping with PHOENIX in pharmaceutical wholesale and pharmacy retail across European markets.

TypeBroad incumbent
Description

Cardinal Health is a major US-headquartered pharmaceutical distributor with international operations, comparable to PHOENIX in pharmaceutical wholesale scale and the integrated manufacturer-to-pharmacy distribution model.

TypeEmerging player
Description

Redcare Pharmacy is a leading European online pharmacy operating in Germany and other continental markets, competing with PHOENIX's owned retail pharmacies on prescription and OTC fulfillment through digital-first economics.

TypeDirect peer
Description

Alliance Healthcare is the European pharmaceutical wholesale and pharmacy distribution arm of Walgreens Boots Alliance, directly competing with PHOENIX Group in pharmaceutical wholesale across multiple European markets and operating retail pharmacy networks.

TypeRegional player
Description

Medipal Holdings is Japan's largest pharmaceutical wholesaler with a business model directly comparable to PHOENIX's wholesale operations; while focused on Japan, it illustrates the regional wholesale archetype PHOENIX dominates in Europe.

TypeOthers
Description

Owens & Minor is a global healthcare logistics and medical supply distributor with a comparable medical products distribution infrastructure to PHOENIX's Health Logistics and transmed operations, though focused more on acute care supplies than retail pharmacy.

TypeBroad incumbent
Description

Cencora is one of the largest global pharmaceutical distributors, comparable to PHOENIX as a wholesale distributor serving pharmacies and manufacturers; while headquartered in the US, it operates internationally and competes with European wholesalers for manufacturer relationships.

TypeRegional player
Description

Sundrug is a major Japanese drugstore chain with vertically integrated wholesale capabilities; while operating in a different geography, it is structurally comparable to PHOENIX's retail pharmacy and cooperation programme model of serving end consumers and independent pharmacies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries25 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Phoenix Group

Pharmaceutical Wholesale and Retailphoenixgroup.eu

Phoenix Group is a family-owned European pharmaceutical wholesaler and pharmacy retailer operating 224 distribution sites and over 3,300 owned pharmacies across 29 countries, serving 189 million people annually through integrated wholesale, retail, and pharmacy cooperation programmes.

What Phoenix Group does

PHOENIX Group (legal entity PHOENIX Pharma SE) is a privately held, family-owned pharmaceutical wholesale and pharmacy retail group headquartered in Mannheim, Germany. Founded in 1994, the company operates across 29 European countries with approximately 49,000 employees, 224 distribution sites, and over 3,300 owned pharmacies in 17 countries serving roughly 189 million people annually. It runs three integrated business lines: pharmaceutical wholesale to pharmacies and medical facilities, direct pharmacy retail under multi-country brands (BENU across 13 countries, Apotek 1 in Norway, Help Net in Romania, Rowlands Pharmacy in the UK, McCabes in Ireland, plus many regional labels), and pharmacy cooperation programmes that support independent pharmacies through networks such as PHOENIX Pharmacy Partnership, NUMARK, Pharma Point, pharmavie, ADIVA, SZIMPATIKA, VALORE SALUTE, and Pharmactiv. A fourth stream provides logistics, marketing, and distribution services to pharmaceutical manufacturers, leveraging subsidiaries such as transmed, Health Logistics, ADG, and Specific Pharma.

The group's operating technology stack centers on pharmaceutical distribution logistics: temperature-controlled cold-chain handling, automated picking and sorting in distribution centers, patient-individual blister packaging, and the PHOENIX Apothekenportal (a digital pharmacy portal with DATEV accounting integration). PHOENIX has been a participant in the European Medicines Verification System since February 2019 under the EU Falsified Medicines Directive, scanning every prescription pack for authenticity. The company is currently rolling out a lean management program (introduced two years prior and recognized via the LEAN Award 2025), and has set a target of CO2 neutrality in its own operations by 2030 while preparing for the EU Corporate Sustainability Reporting Directive (CSRD).

PHOENIX generates revenue through transaction-based wholesale distribution, pharmacy retail sales, recurring subscription-like fees from pharmacy cooperation programmes, and professional services to pharmaceutical manufacturers. Pricing is negotiated on a contract basis with no public rate cards. The group is led by CEO Sven Seidel and CFO Dr. Carsten Sauerland, with a planned Executive Board transition effective 1 February 2026 in which Joachim Sowada and Wolfgang Wallisch will replace outgoing members Steve Anderson and Stefan Herfeld. No public revenue figures are disclosed.

Phoenix Group firmographics

Firmographics
Name
Phoenix Group
Legal name
PHOENIX Pharma SE
Website
https://phoenixgroup.eu
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Phoenix Group is a family-owned European pharmaceutical wholesaler and pharmacy retailer operating 224 distribution sites and over 3,300 owned pharmacies across 29 countries, serving 189 million people annually through integrated wholesale, retail, and pharmacy cooperation programmes.
Ownership category
akta.pro rank

Phoenix Group industry classification

Industry
Product category
Pharmaceutical Wholesale and Retail
NAICS
Pharmacies and Drug Retailers (456110), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Retail & Community Pharmacies (Chain/Independent) (HLAFALAA)
akta.pro secondary industry
Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

  • Pharmaceutical wholesale
  • Pharmacy retail
  • Pharmaceutical distribution
  • Pharmacy cooperation
  • Cold chain logistics

Where Phoenix Group is headquartered

Location

Headquarters

HQ city
Mannheim
HQ country
Germany
HQ region
Europe

Offices5 records

Markets served

Phoenix Group business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Wholesale: Distribution of pharmaceutical products from manufacturers to pharmacies and medical facilities across 29 European countries
  2. Pharmacy Retail: Operation of over 3,200 owned pharmacies in 17 European countries serving end consumers directly
  3. Pharmacy Cooperation Programmes: Services and support to independent pharmacies through franchise and partnership models across Europe
  4. Services for Pharmaceutical Industry: Logistics, marketing, and distribution services for pharmaceutical manufacturers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Phoenix Group product offering

Product offering

Core offering

Phoenix Group is a pan-European integrated pharmaceutical healthcare provider that distributes medicines and healthcare products to pharmacies and medical facilities through 224 distribution sites across 29 countries, and operates over 3,200 own pharmacies in 17 countries. The company also runs pharmacy cooperation programmes that supply independent pharmacies with purchasing, marketing, and digital services across Europe.

Product overview

PHOENIX Group is a pan-European integrated healthcare provider operating three core business segments: pharmaceutical wholesale (224 distribution centers across 29 countries), pharmacy retail (over 3,300 owned pharmacies in 17 countries), and pharmacy cooperation programmes supporting independent pharmacies. The company offers an extensive portfolio of regional sub-brands including BENU (13 countries), Apotek 1 (Norway), Help Net (Romania), Rowlands Pharmacy (UK), McCabes (Ireland), BROCACEF (Netherlands), FARMEXIM (Romania), Nomeco (Denmark), Tamro (5 countries), and numerous other regional pharmacy and wholesale brands. Supporting services include health logistics (Health Logistics, transmed), pharmacy portal technology (PHOENIX Apothekenportal with DATEV integration), patient services (individual blistering, nurse care programmes), and pharmacy cooperation networks (NUMARK, Pharma Point, VALORE SALUTE, Pharmactiv, and others) spanning over 29 countries. The company employs approximately 49,000 colleagues serving 189 million people annually across Europe.

Differentiator

Problem solved

Functional benefit

Brands

  • PHOENIX Pharmazie Wissenschaftspreis: Annual pharmaceutical science award recognizing outstanding research in Germany, Austria, and Switzerland, with prize money of 40,000 euros distributed across four categories.

Products and services

  • Pharmaceutical Wholesale
  • Pharmacy Retail
  • Pharmacy Cooperation Programmes
  • Healthcare Logistics Services
  • PHOENIX Apothekenportal (Pharmacy Portal)
  • Patient Individual Blistering
  • Nurse Care Programme
  • Services for Pharmaceutical Industry

Quantifiable outcome

  • 189 million people supplied with medicines and healthcare products annually
  • +2 more outcomes

Companies that use Phoenix Group

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Phoenix Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

Feature4 records

Phoenix Group partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • LINDA AGcoreStrategic or Co-development Partner · 1 January 2023Expanded strategic partnership announced at LINDA Delegiertenkongress 2022, providing enhanced cooperation between PHOENIX Pharmahandel and LINDA independent pharmacy network in German-speaking markets.
  • European Medicines Verification System (EMVS)coreTechnology or Integration · 1 January 2019PHOENIX Group participates in the EU Falsified Medicines Directive (FMD) verification system, scanning every prescription medicine package for authenticity since February 2019.
  • PAYBACKcoreGTM or Marketing Partner · 1 January 2005Long-standing partnership since 2005 for loyalty programme integration, recently expanded with long-term extension. Provides consumer loyalty services through pharmacy networks.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Phoenix Group competitors and assessment

Company assessment

Emerging players

  • DocMorris: DocMorris is a pan-European online pharmacy and healthcare platform headquartered in the Netherlands, competing directly with PHOENIX's retail pharmacy brands (Brocacef, Apotek 1, Help Net) on cross-border mail-order prescription and OTC business.
  • Redcare Pharmacy (formerly Shop Apotheke Europe): Redcare Pharmacy is a leading European online pharmacy operating in Germany and other continental markets, competing with PHOENIX's owned retail pharmacies on prescription and OTC fulfillment through digital-first economics.

Broad incumbents

  • Walgreens Boots Alliance: Walgreens Boots Alliance is a global pharmacy-led health and wellbeing enterprise whose Alliance Healthcare wholesale arm and Boots retail pharmacy network compete with PHOENIX's wholesale and retail pharmacy segments across Europe.
  • McKesson: McKesson is a global pharmaceutical distributor and healthcare services company that previously owned Celesio/Lloyds Pharmacy, directly overlapping with PHOENIX in pharmaceutical wholesale and pharmacy retail across European markets.
  • Cardinal Health: Cardinal Health is a major US-headquartered pharmaceutical distributor with international operations, comparable to PHOENIX in pharmaceutical wholesale scale and the integrated manufacturer-to-pharmacy distribution model.
  • Cencora (formerly AmerisourceBergen): Cencora is one of the largest global pharmaceutical distributors, comparable to PHOENIX as a wholesale distributor serving pharmacies and manufacturers; while headquartered in the US, it operates internationally and competes with European wholesalers for manufacturer relationships.

Direct peers

  • Alliance Healthcare (Walgreens Boots Alliance): Alliance Healthcare is the European pharmaceutical wholesale and pharmacy distribution arm of Walgreens Boots Alliance, directly competing with PHOENIX Group in pharmaceutical wholesale across multiple European markets and operating retail pharmacy networks.

Regional players

  • Medipal Holdings: Medipal Holdings is Japan's largest pharmaceutical wholesaler with a business model directly comparable to PHOENIX's wholesale operations; while focused on Japan, it illustrates the regional wholesale archetype PHOENIX dominates in Europe.
  • Sundrug: Sundrug is a major Japanese drugstore chain with vertically integrated wholesale capabilities; while operating in a different geography, it is structurally comparable to PHOENIX's retail pharmacy and cooperation programme model of serving end consumers and independent pharmacies.

Others

  • Owens & Minor: Owens & Minor is a global healthcare logistics and medical supply distributor with a comparable medical products distribution infrastructure to PHOENIX's Health Logistics and transmed operations, though focused more on acute care supplies than retail pharmacy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Phoenix Group social profiles

Digital presence

Phoenix Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Phoenix Group leadership team

Management profile

Number of profiles

Profiles9 records

Phoenix Group subsidiaries and ownership

Company hierarchy

Subsidiaries25 records

Phoenix Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Phoenix Group M&A and investment

M&A and investment

M&A1 record

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phoenix Group

What does Phoenix Group do?

Phoenix Group is a pan-European integrated pharmaceutical healthcare provider that distributes medicines and healthcare products to pharmacies and medical facilities through 224 distribution sites across 29 countries, and operates over 3,200 own pharmacies in 17 countries. The company also runs pharmacy cooperation programmes that supply independent pharmacies with purchasing, marketing, and digital services across Europe.

Is Phoenix Group a public or private company?

Phoenix Group is a private company. It is classified as family owned and is currently operating.

When was Phoenix Group founded?

Phoenix Group was founded in 1994. It employs 5,001 to 10,000 people.

Where is Phoenix Group based?

Phoenix Group is headquartered in Mannheim, Germany, in the Europe region.

How does Phoenix Group make money?

Four revenue lines are on record. Pharmaceutical Wholesale is the primary driver. The others are pharmacy Retail, pharmacy Cooperation Programmes and services for Pharmaceutical Industry.

Who are Phoenix Group's main competitors?

Emerging players on record are DocMorris and Redcare Pharmacy (formerly Shop Apotheke Europe). Broad incumbents are Walgreens Boots Alliance, McKesson, Cardinal Health and Cencora (formerly AmerisourceBergen). Alliance Healthcare (Walgreens Boots Alliance) is listed as a direct peer. Regional players are Medipal Holdings and Sundrug. Owens & Minor is listed as an others.

Does Phoenix Group have an API?

No public API is recorded for Phoenix Group.

What industry is Phoenix Group in?

Phoenix Group's product category is Pharmaceutical Wholesale and Retail. Its primary akta.pro industry code is HLAFALAA, Retail & Community Pharmacies (Chain/Independent), with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 456110 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IpeFurther M&A activity expected in UK pension and risk transfer marketThree major bulk annuity insurer acquisitions were announced in the UK in 2025, with Athora acquiring Pension Insurance Corporation for £5.7bn, Brookfield Wealth Solutions buying Just Group for £2.4bn, and JAB Insurance acquiring Utmost's life and pensions arm representing over £5bn in assets. LCP forecasts UK buy-in volume to reach a record £55bn in 2026, with continued interest expected from overseas investors. Strategic partnerships such as the Legal & General and Blackstone tie-up are also reshaping the market, with Phoenix Group reportedly in talks over a similar model.DirectorsTalk InterviewsPhoenix Group Holdings PLC (PHNX.L): Navigating the Challenges and Opportunities in Life InsurancePhoenix Group Holdings PLC is a major player in the UK life insurance industry, with a focus on retirement and savings products. The company faces operational challenges, including a significant revenue contraction and negative earnings, but maintains financial flexibility with strong cash flow.MarketScreenerPhoenix Group optimistic on full-year cash generationPhoenix Group Holdings PLC reported that its incremental new business long-term cash generation more than doubled in the first half of 2023 to GBP885 million from GBP430 million a year prior, while new business net fund flows surged 72% to GBP3.1 billion. The company predicts 2024 will be its first positive year for net fund flows, meaning new business inflows will offset Heritage run-off outflows for the first time. Phoenix declared a 26.0 pence per share interim dividend, up 4.8% from 24.8p a year prior, and completed the acquisition of Sun Life of Canada UK Ltd from Sun Life Financial Inc in April for GBP248 million.FinSMEsPractio Closes €8.2 Funding RoundPractio ApS, a Danish digital healthcare platform, raised €8.2M in equity, loan conversion, and debt financing. Backers include Phoenix group, Spintop Ventures, and Carl Westin. The company will use the funds to accelerate UK deployment and enter Germany later this year.